 | Banović, Pavle TREATMENT OF A PATIENT INJURED BY THE CENTIPEDE SCOLOPENDRA CINGULATA (LATERILLE, 1829) Journal Article MD-Medical Data, 9 (3), pp. 185-187, 2017. Садржај | Линкови | BibTeX @article{article,
title = {TREATMENT OF A PATIENT INJURED BY THE CENTIPEDE SCOLOPENDRA CINGULATA (LATERILLE, 1829)},
author = {Pavle Banović},
url = {https://www.pasterovzavod.rs/wp-content/uploads/2019/02/09-MD-Vol-9-No3_Banovic-5-1.pdf},
year = {2017},
date = {2017-09-13},
journal = {MD-Medical Data},
volume = {9},
number = {3},
pages = {185-187},
abstract = {Scolopendra cingulata (Laterille, 1829) was noticed sixty years ago for the first time in one location in Serbia and since then data about it are scarce. It represents the biggest centipede in Europe and only one that can seriously harm humans. Scolopendrism in Republic of Serbia is a true rarity and until now there has been no case report of harming human by centipede Scolopendra cingulata (Laterille, 1829). Patient aged 85, was stung on his right leg toe by unknown centipede in the toilet of his home. The centipede was afterwards identified as Scolopendra cingulata. As a chief complaint patient describes intense pain at the sting site and burning feeling that spreads to the hip joint. The objective finding revealed a slight redness of the affected area. He was ordinated 20mg chloropyramine (Synopen), 2x4mg dexamethasone and 40mg methylprednisolone i.v. 24 hours after centipede attack pain was completely gone and the patient could walk freely. Although there is a possibility that a species located in our country's territory exhibits phenotypes and genotype differences in relation to the more widely described Mediterranean type, each human bitten by i.e. that come into contact with Scolopendra cingulata venom should be taken seriously in order to facilitate the patient's symptoms, manage constant monitoring and prevent the development of isolated or associated complications with potential comorbidities of the patient.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Scolopendra cingulata (Laterille, 1829) was noticed sixty years ago for the first time in one location in Serbia and since then data about it are scarce. It represents the biggest centipede in Europe and only one that can seriously harm humans. Scolopendrism in Republic of Serbia is a true rarity and until now there has been no case report of harming human by centipede Scolopendra cingulata (Laterille, 1829). Patient aged 85, was stung on his right leg toe by unknown centipede in the toilet of his home. The centipede was afterwards identified as Scolopendra cingulata. As a chief complaint patient describes intense pain at the sting site and burning feeling that spreads to the hip joint. The objective finding revealed a slight redness of the affected area. He was ordinated 20mg chloropyramine (Synopen), 2x4mg dexamethasone and 40mg methylprednisolone i.v. 24 hours after centipede attack pain was completely gone and the patient could walk freely. Although there is a possibility that a species located in our country's territory exhibits phenotypes and genotype differences in relation to the more widely described Mediterranean type, each human bitten by i.e. that come into contact with Scolopendra cingulata venom should be taken seriously in order to facilitate the patient's symptoms, manage constant monitoring and prevent the development of isolated or associated complications with potential comorbidities of the patient. |
| Ristanović, Elizabeta; Atanasievska, Sonja; Protić-Đokić, Vesna; Hinić, Nataša; Lalošević, Dušan MICROBIOLOGICAL DETECTION OF BORRELIA BURGDORFERI AND CONTEMPORARY DIAGNOSIS OF LYME BORELLOSIS Journal Article MD Medical review, 9 (3), pp. 143-147, 2017. Садржај | Линкови | BibTeX @article{article,
title = {MICROBIOLOGICAL DETECTION OF BORRELIA BURGDORFERI AND CONTEMPORARY DIAGNOSIS OF LYME BORELLOSIS},
author = {Elizabeta Ristanović and Sonja Atanasievska and Vesna Protić-Đokić and Nataša Hinić and Dušan Lalošević},
url = {https://www.pasterovzavod.rs/wp-content/uploads/2019/02/01-MD-Vol-9-No3_Ristanovic-et-al.pdf},
year = {2017},
date = {2017-08-24},
journal = {MD Medical review},
volume = {9},
number = {3},
pages = {143-147},
abstract = {Lyme borreliosis is a multi-system disease caused by Borrelia burgdorferi, which is transmitted by hard ticks Ixodes spp. The most common clinical manifestation is the skin lesion (erythema migrans), however there is a tendency of the pathogen to spread and cause damages to the joints, nervous and cardiovascular system. The diagnosis of Lyme disease is based primarily on clinical findings, epidemiological and anamnestic data and laboratory test results. The application of the modern real-time PCR method allows us to test the skin in tick bite area for a presence of B. burgdorferi. In the diagnosis of Lyme disease, we often use indirect methods (TIIF, ELISA, Western blot) for detecting specific IgM and IgG antibodies against B. burgdorferi in serum, liquor and synovial fluid. To confirm the diagnosis, the presence of IgG antibodies should be demonstrated, since the presence of IgM is not a relible indicator of a recent infection. When interpreting immunodiagnostic test results it has to be considered that there are a lot of variability as the phenotype characteristics of borrelia, different antigenic structures, different geographical distribution, phase varies in duration of the disease, characteristics of individual immune responses, presence of other diseases as well as the applied antibiotic treatment, which all can affect the outcome. Due to the high presence of infected ticks in our geographical area, it is necessary to provide continuous preventive measures, epidemiological monitoring and improvement of the diagnostic and therapeutic approach in the treatment of Lyme borreliosis.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Lyme borreliosis is a multi-system disease caused by Borrelia burgdorferi, which is transmitted by hard ticks Ixodes spp. The most common clinical manifestation is the skin lesion (erythema migrans), however there is a tendency of the pathogen to spread and cause damages to the joints, nervous and cardiovascular system. The diagnosis of Lyme disease is based primarily on clinical findings, epidemiological and anamnestic data and laboratory test results. The application of the modern real-time PCR method allows us to test the skin in tick bite area for a presence of B. burgdorferi. In the diagnosis of Lyme disease, we often use indirect methods (TIIF, ELISA, Western blot) for detecting specific IgM and IgG antibodies against B. burgdorferi in serum, liquor and synovial fluid. To confirm the diagnosis, the presence of IgG antibodies should be demonstrated, since the presence of IgM is not a relible indicator of a recent infection. When interpreting immunodiagnostic test results it has to be considered that there are a lot of variability as the phenotype characteristics of borrelia, different antigenic structures, different geographical distribution, phase varies in duration of the disease, characteristics of individual immune responses, presence of other diseases as well as the applied antibiotic treatment, which all can affect the outcome. Due to the high presence of infected ticks in our geographical area, it is necessary to provide continuous preventive measures, epidemiological monitoring and improvement of the diagnostic and therapeutic approach in the treatment of Lyme borreliosis. |
